NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Becomes First Commercial Site to Deploy Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
HOPE Therapeutics, a wholly-owned subsidiary of NRx Pharmaceuticals, has become the first commercial site to deploy Zeta Surgical's FDA-cleared Zeta TMS Navigation System. The system, installed at HOPE's West Palm Beach clinic, uses AI-driven image guidance to deliver sub-millimetric precision for Transcranial Magnetic Stimulation (TMS) in treating Major Depressive Disorder.
Key figures
- Precision
- sub-millimetric
- Setup time
- under two minutes per session
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.